Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...

Difference from Background: Limit of Detection

Difference from Background: Limit of Detection

The limit of detection (LOD) is the smallest amount of analyte that can be distinguished from the background noise. The LOD value corresponds to the concentration at which the analyte signal is three times larger than the standard deviation of the blank signal. Below this value, the analyte signal cannot be differentiated from the background noise. It is calculated by dividing the calibration slope by 3 times the standard deviation of the blank signals.
The LOD indicates the presence or absence...

Masking and Demasking Agents

Masking and Demasking Agents

EDTA titrations may necessitate masking and demasking agents to temporarily protect a particular metal ion in a mixture from the EDTA reaction. These agents facilitate the sequential analysis of the metal ions by forming stable complexes with some—but not all—metal ions during certain steps.
There are many masking agents, such as cyanide, fluoride, triethanolamine, thiourea, and 2,3-bis(sulfanyl)propan-1-ol (formerly 2,3-dimercapto-1-propanol), with the masking agent chosen based on the metal...

PPE Use in Healthcare Settings II: Doffing

PPE Use in Healthcare Settings II: Doffing

The sequence of removing or doffing PPE starts with the gloves, as they are the most contaminated. Next is removal of the face shield or goggles, as they would interfere with removing other PPE. Then remove the gown, followed by the mask or respirator. Perform hand hygiene between steps if hands become contaminated and immediately after removing all PPE. Generally, the outside front and sleeves of the isolation gown, the goggles or the mask, the respirator, and the face shield are contaminated.

Desensitization and Tachyphylaxis

Desensitization and Tachyphylaxis

Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...

Transmission-based Precautions I: Contact, Enteric, and Droplets

Transmission-based Precautions I: Contact, Enteric, and Droplets

Transmission-based precautions are for patients known to be infected or suspected to be infected or colonized with organisms that pose a significant risk to others. Some transmission-based precautions include contact, enteric, and droplet.
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Modeling external exposure to pesticides in human populations: Developing an exposure scenario generator.

Ecotoxicology and environmental safety·2026

Same author

The long way from raw data to NAM-based information: Overview on data layers and processing steps.

ALTEX·2025

Same author

The Virtual Human Platform for Safety Assessment (VHP4Safety) project: Next generation chemical safety assessment based on human data.

ALTEX·2024

Same author

Biodistribution of cerium dioxide and titanium dioxide nanomaterials in rats after single and repeated inhalation exposures.

Particle and fibre toxicology·2024

Same author

New Approach Methodologies (NAMs) for ad hoc human health risk assessment of food and non-food products - Proceedings of a workshop.

Regulatory toxicology and pharmacology : RTP·2024

Same author

Comparative, collaborative, and integrative risk governance for emerging technologies.

Environment systems & decisions·2023

Search research articles

Related Experiment Video

Updated: Jun 10, 2026

X-ray Dose Reduction through Adaptive Exposure in Fluoroscopic Imaging

X-ray Dose Reduction through Adaptive Exposure in Fluoroscopic Imaging

Published on: September 11, 2011

Exposure-based waiving under REACH.

Theo Vermeire¹, Marja van de Bovenkamp, Yuri Bruinen de Bruin

¹National Institute for Public Health and the Environment (RIVM), P.O. Box 1, 3720 BA Bilthoven, The Netherlands. theo.vermeire@rivm.nl

Regulatory Toxicology and Pharmacology : RTP

|August 18, 2010

Summary

This summary is machine-generated.

Exposure-based waiving (EBW) reduces animal testing by assessing low human or environmental exposure risks. This strategy, detailed under REACH regulations, prioritizes risk management over additional testing when exposure is minimal.

More Related Videos

Effective Analysis of Human Exposure Conditions with Body-worn Dosimeters in the 2.4 GHz Band

Effective Analysis of Human Exposure Conditions with Body-worn Dosimeters in the 2.4 GHz Band

Published on: May 2, 2018

Whole-Body Nanoparticle Aerosol Inhalation Exposures

Whole-Body Nanoparticle Aerosol Inhalation Exposures

Published on: May 7, 2013

Related Experiment Videos

Last Updated: Jun 10, 2026

X-ray Dose Reduction through Adaptive Exposure in Fluoroscopic Imaging

X-ray Dose Reduction through Adaptive Exposure in Fluoroscopic Imaging

Published on: September 11, 2011

Effective Analysis of Human Exposure Conditions with Body-worn Dosimeters in the 2.4 GHz Band

Effective Analysis of Human Exposure Conditions with Body-worn Dosimeters in the 2.4 GHz Band

Published on: May 2, 2018

Whole-Body Nanoparticle Aerosol Inhalation Exposures

Whole-Body Nanoparticle Aerosol Inhalation Exposures

Published on: May 7, 2013

Area of Science:

Chemical safety assessment
Risk management strategies
Regulatory compliance

Background:

The Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) framework and OECD recognize the need to limit animal testing due to ethical, economic, and logistical concerns.
Exposure-based waiving (EBW) is a key strategy for reducing the number of required chemical safety tests.

Purpose of the Study:

To describe the criteria for exposure-based waiving (EBW) as outlined in REACH regulations.
To provide detailed insights into REACH requirements for implementing EBW.
To analyze the risk-based principles underpinning EBW.

Main Methods:

Analysis of exposure models and their prediction uncertainties.
Evaluation of no-effect criteria, including the threshold of toxicological concern (TTC).
Examination of case studies for environmental, consumer, and worker exposure scenarios.

Main Results:

EBW is applicable when human or environmental exposures are sufficiently low, minimizing the need for additional toxicological data to manage risks.
REACH imposes specific constraints on EBW, including tonnage limits, types of waived tests, and comprehensive lifecycle exposure assessments.
Industry adoption of EBW is contingent on cost-benefit analyses, particularly valuing the reduction of animal testing.

Conclusions:

EBW is a risk-based approach requiring robust understanding of both exposure and effects data.
Successful implementation of EBW under REACH necessitates thorough exposure assessments across all relevant pathways and exposure routes.
The economic viability and ethical considerations of reducing animal testing significantly influence the practical application of EBW.